Abstract:Background: Presently, viral vector used in gene therapy has immunogenicity to the body and has a potential to infect, so it has limitation to be used in clinic. Onjective: To construct the non-pathogenic recombinant adeno-associated virus (AAV) simultaneously carrying human vascular endothelial growth factor 165 (hVEGF 165) gene and green fluorescent protein (GFP) label, and assess its biological activity and function by infecting rabbit bone marrow mesenchymal stem cells (BMSCs) in vitro. Design, Time and Setting: An open experiment was performed at the Laboratory of Virus of Shanxi Provincial Center for Disease Control and Prevention between March and November 2007. Materials: BMSCs were harvested from mature New Zealand rabbits after primary culture by the experimenter. Human umbilical vein endothelial cells (HUVECs) were harvested from infant umbilical cores of healthy parturients. Informed consents were obtained from parturients. Methods: Plasmid pAAV-hVEGF 165-IRES-hrGFP was constructed by hVEGF 165 segments amplified from plasmid pUC18-hVEGF165 carrying hVEGF 165 gene. The recombinant expression plasmid pAAV-hVEGF165-IRES-hrGFP was co-transfected into AAV-293 cells with pAAV-Helper and pAAV-RC for recombinant AAV replication and package through homologous recombination. In vitro cultured rabbit BMSCs were infected with this recombinant virus. Main Outcome Measure: The efficiency of AAV packaging was monitored under a fluorescent microscope and the virus titer was measured through infecting AAV-HT1080, and the recombinant virus was verified by polymerase chain reaction (PCR) of the exogenous interest gene. Through infecting rabbit bone marrow mesenchymal stem cells in vitro, the infection efficiency was detected. The expression of VEGF 165 in BMSCs was detected by enzyme linked immunosorbent assay (ELISA), and its biological activity was assessed by angiopoiesis experiment of HUVECs in vitro. Results: The hVEGF 165 gene was successfully amplified and recombinant pAAV-hVEGF 165-IRES-GFP was verified by double digestion. The system provided a high packing ratio of more than 95% and the purified recombinant virus had a high titer of 5.5 × 10 11 vp/mL. The recombinant virus was confirmed by exogenous human VEGF 165 gene PCR. The rAAV-VEGF 165-GFP could infect rabbit BMSCs at a ratio of 40%. With rAAV-VEGF165-GFP infection, the expression of VEGF 165 in the conditional medium was detected by ELISA at a concentration of (85.58±5.37) μ g/L 72 hours after infection. HUVECs became extended, deformed, pullulation, cross-linking and showing tube-shape affected by VEGF protein. Conclusion: The non-pathogenic rAAV-hVEGF 165-GFP simultaneously carrying hVEGF 165 and GFP label is successfully constructed, with the ability of infecting rabbit BMSCs to efficiently express hVEGF 165, and hVEGF 165 expressed in BMSCs has a satisfying biological activity of stimulation of HUVECs proliferation.

Construction of eukaryotic expression vector for human angiopoietin 1 and its expression in the marrow mesenchymal stem cells of rabbit]

[Expression of Human VEGF165 Gene in Rat Bone Marrow Stromal Cells in Vitro].

REPAIR OF RADIAL SEGMENTAL BONE DEFECTS BY COMBINED ANGIOPOIETIN 1 GENE TRANSFECTED BONE MARROW MESENCHYMAL STEM CELLS AND PLATELET-RICH PLASMA TISSUE ENGINEERED BONE IN RABBITS

Effects of Recombinant Adeno-Associated Viral Vectors on Angiopoiesis and Osteogenesis in Cultured Rabbit Bone Marrow Stem Cells Via Co-Expressing Hvegf and Hbmp Genes: A Preliminary Study in Vitro

Effect of bone marrow mesenchymal stem cells transfected with angiopoietin-1 on the renovation and neovascularization of bone defects in rabbits

Experimental Repair of Segmental Bone Defects in Rabbits by Angiopoietin‐1 Gene Transfected MSCs Seeded on Porous Β‐tcp Scaffolds

The Ectopic Study of Tissue-Engineered Bone with Hbmp-4 Gene Modified Bone Marrow Stromal Cells in Rabbits

CONSTRUCTION OF LENTIVIRAL VECTOR CONTAINING HOMO SAPIENS FORKHEAD BOX C2 GENE AND ITS EXPRESSION IN BONE MARROW MESENCHYMAL STEM CELLS OF RABBITS

The Construction of Mesenchymal Stem Cells Carrying Angiopoietin 1 and Its Application in Lung Injury

Construction of recombinant adeno-associated virus carrying human vascular endothelial growth factor 165 and in vitro infection of bone marrow mesenchymal stem cells

Effect of bone mesenchymal stem cells for constructing artificial bone in accelerating bone repair of rabbit femoral head necrosis

Construction and expression in vitro of bone morphogenetic protein 2 eukaryotic experssion vector

Angiopoiesis and Bone Regeneration Via Co-Expression of the Hvegf and Hbmp Genes from an Adeno-Associated Viral Vector in Vitro and in Vivo.

Experimental Study of TCP with Bone Mesenchymal Stem Cells Transfected with Ang-1 Gene on Bone Repair and Neovascularsation of Rabbit Radius Defect Model

[Construction of Eukaryotic Vector of Bone Morpbogenetic Protein-7 and Its Expression in MC3T3-E1 Cells].

Human nerve growth factor beta-modified bone marrow mesenchymal stem cells from the rabbit mandible by transfection of lentiviral vectors

Expression of Human Vegf(121) Cdna in Mouse Bone Marrow Stromal Cells

Construction of Recombinant Adeno-Associated Virus Carrying Human Bone Morphogenetic Protein-7 and in Vitro Infection of Bone Marrow Mesenchymal Stem Cells

Construction of seed cells with the stable expression of human bone morphogenetic protein 2 gene for bone tissue engineering

Reconstruction and Identification of Adenovirus Expression Vector for Human Transforming Growth Factor Β1

Enhancement of Bone Formation by Genetically-Engineered Bone Marrow Stromal Cells Expressing BMP-2, VEGF and Angiopoietin-1.